Can gefitinib treat lung squamous cell carcinoma?

Squamous cell carcinoma is a subtype of lung cancer often associated with smoking. Treatment methods for lung squamous cell carcinoma include surgical resection, radiation therapy, chemotherapy and targeted therapy. Gefitinib may be effective in some patients with lung squamous cell carcinoma, especially those with specific genetic mutations. In some clinical trials, gefitinib has been shown to improve survival to some extent in patients with lung squamous cell carcinoma. However, the optimal treatment for lung squamous cell carcinoma should be determined based on the patient's specific circumstances and pathological characteristics. Therefore, if you or someone you know has lung squamous cell carcinoma, you should consult with a medical professional to determine the most appropriate treatment options and to learn whether gefitinib may be appropriate for your case. Early diagnosis and individualized treatment options often improve treatment success and survival rates.